Member Info for Lp160606

course i've averaged down and on that news i have reduced by 80%.

May well miss out on Beckman but if you all think that useless basterd at the helm will deliver you're off your heads.

rumour mil?

Mate the CEO of Divoc posted it. This isn't a debate.

What part of my statement is incorrect chaps? Humour me.

The numbers are very poor. targeting 20 sites in Delhi alone.. how many they currently got?

I said in early September the Beckman opportunity was the only viable savour for GDR as an investment opp, and with those sort of piddly numbers is rings more true now than ever.

Iphoneitrade - you've been here a few weeks and know f all of GDR, just a poxy little trader.

It is literally here.

https://www.linkedin.com/feed/update/urn:li:activity:6714435609311666176/?commentUrn=urn%3Ali%3Acomment%3A(activity%3A6714427174490820608%2C6714435556484419584)

GDR continues to disappoint when it comes to their partnerships. imagine focusing on high throughput labs for your key partner in India to disclose this. pathetic.

Beckman or bust.

Moil got the info from a comment Kanav made on linkedin.

He responded to a question regarding max capacity, stating they could process between 900 - 1000 samples per day.

So 1000 is their capacity at present.

Pretty ****house total output tbf.

@John, Add Beckman into the mix.

If you check his Twitter again they have processed swabs.

I don’t think it is us.

TB,

Fail to mention the Beckman outlet, which alone, could dwarf any other engagement.

Although i understand why you have a poor outlook, trust me i've sat through it since may and seen GDR disappoint countless times, Beckman has the potential to be huge and internal validation bypasses FDA meaning no regulatory hiccups to worry about.

hmmm is it our test?

I know it is all over their website but we do not yet have official ICMR approval.

Lol don't Mushy.. nerves will be in pieces.

So essentially support collateral (i think)

It's sample dossier here - https://www.who.int/diagnostics_laboratory/13046_simu_doc_cd4_feb27th.pdf

That link takes you to a sample dossier created by WHO to support test manufactures.

Dossier review.

Because approval is not complete. Still another stage to finalise.

Cracking development mate. QMS desk stage complete!

Agree with you, PP.

Although the delays do my head in, v unlikely Beckman made a mistake in aligning with our test. They’d of known the benefits prior to the announcement of partnership (id of thought).

The wider market influences are creating the perfect melting pot for news to be delivered here. I’m hopeful it comes this week.

Iphonetrade I can buy and sell at a fairly decent volume so although I appreciate the high level attempted lesson, it isn’t needed.

I also don’t feel the need to lie about it being NT for hours at a time unlike some here.

Yes it does change very quick... write a figure and go to check it again and it reads something else.

Yes but we are 8.33% down. Not within the 4-6 range.

We appear to be getting hit hardest.

Although hard to distinguish this market free fall coincides with another passing Deadline.

7 weeks today since the beckman RNS.